Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Phase I/IIa, Multicentre, Interventional Single-arm Trial of MB-CART19.1 in Patients With Refractory SLE

NCT06189157 is registered in ClinicalTrials.gov with Miltenyi Biomedicine GmbH as lead sponsor.

NCT NCT06189157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06189157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Phase I/IIa, Multicentre, Interventional Single-arm Trial of MB-CART19.1 in Patients With Refractory SLE
Lead sponsor
Miltenyi Biomedicine GmbH
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 12, 2024
Completion date
September 30, 2027
Enrollment
29 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sle - systemic lupus erythematosus